1. Home
  2. STRT vs OBIO Comparison

STRT vs OBIO Comparison

Compare STRT & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$80.00

Market Cap

255.2M

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.12

Market Cap

240.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRT
OBIO
Founded
1908
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.2M
240.7M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
STRT
OBIO
Price
$80.00
$4.12
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$93.00
$14.25
AVG Volume (30 Days)
78.1K
238.0K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
12.53
33.13
EPS
4.04
N/A
Revenue
$439,195,000.00
$33,482,000.00
Revenue This Year
$4.22
N/A
Revenue Next Year
$2.04
$12.43
P/E Ratio
$19.50
N/A
Revenue Growth
5.24
1169.22
52 Week Low
$56.02
$2.20
52 Week High
$92.50
$5.42

Technical Indicators

Market Signals
Indicator
STRT
OBIO
Relative Strength Index (RSI) 60.47 55.34
Support Level $72.83 $4.07
Resistance Level $84.20 $4.18
Average True Range (ATR) 3.53 0.18
MACD 0.45 0.03
Stochastic Oscillator 75.39 87.50

Price Performance

Historical Comparison
STRT
OBIO

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: